Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-22-002439
Filing Date
2022-01-18
Accepted
2022-01-18 16:54:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea154141-13ga1alpha_enveric.htm SC 13G/A 40969
  Complete submission text file 0001213900-22-002439.txt   42735
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Subject) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53543 | Film No.: 22535764
SIC: 2834 Pharmaceutical Preparations

Mailing Address LETTSTRASSE 32 FL-9490 VADUZ N2 00000
Business Address LETTSTRASSE 32 FL-9490 VADUZ N2 00000 011-423-2323195
ALPHA CAPITAL ANSTALT (Filed by) CIK: 0001140358 (see all company filings)

EIN.: 000000000 | State of Incorp.: N2
Type: SC 13G/A